Products - HIV and AIDS | Topic | NICE

Showing 4 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Cabotegravir with rilpivirine for the oral treatment of HIV-1 [ID3731]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Fostemsavir for treating adults with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2726]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ibalizumab for treating adults infected with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2720]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Lenacapavir for HIV pre-exposure prophylaxis in people 16 years and over at risk of infection [ID6495]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC